Compounded formulations allow flexible dosing and lower cost ($149/month) without changing tolerability
It is expressed in noradrenergic neurons of the central nervous system (i.e., locus coeruleus) and peripheral nervous systems (i.e., sympathetic ganglia), as well as in chromaffin cells of the adrenal medulla
Use before: 24 Months from Manufacturing Date
Thus, it seems likely that we can look forward to further progress in the field of GLP-1-based therapy
The manufacturers now sell direct to cash-pay patients for far less: Zepbound runs $299 to $449 per month through LillyDirect by dose, and Wegovy runs $349 per month for standard doses through NovoCare Pharmacy ($199 per month on the first two fills through December 2026)
Length selection depends partly on body composition and injection site location, which your provider can assess during your treatment initiation visit